Advertisement

Topics

Edison Issues Initiation on NeuroVive Pharmaceutical (NVP)

06:45 EDT 29 Jun 2017 | FinanzNachrichten

LONDON, UK / ACCESSWIRE / June 29, 2017 / NeuroVive Pharmaceutical (OTCQX: NEVPF) (STO: NVP) is a mitochondrial medicine specialist with a diversified asset portfolio. It employs a two-pronged stra...

Original Article: Edison Issues Initiation on NeuroVive Pharmaceutical (NVP)

NEXT ARTICLE

More From BioPortfolio on "Edison Issues Initiation on NeuroVive Pharmaceutical (NVP)"

Quick Search
Advertisement